ETON PHARMACEUTICALS

eton-pharmaceuticals-logo

Eton Pharmaceuticals is a pharmaceutical company that focuses on developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eight product candidates in various stages of development. It was founded in 2017 and headquartered in Studio City, California.

#SimilarOrganizations #People #Event #Website #More

ETON PHARMACEUTICALS

Industry:
Biopharma Biotechnology Health Care Pharmaceutical

Founded:
2017-01-01

Address:
Studio City, California, United States

Country:
United States

Website Url:
http://www.etonpharma.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
27.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx


Similar Organizations

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.


Current Advisors List

charles-casamento_image

Charles Casamento Board Member @ Eton Pharmaceuticals
Board_member
2017-06-01

paul-maier_image

Paul Maier Board Chairman @ Eton Pharmaceuticals
Board_member
2017-01-01

mark-baum_image

Mark Baum Board Member @ Eton Pharmaceuticals
Board_member
2017-05-01

norbert-riedel_image

Norbert Riedel Board Chairman @ Eton Pharmaceuticals
Board_member

sean-brynjelsen_image

Sean Brynjelsen Board Member @ Eton Pharmaceuticals
Board_member

Current Employees Featured

mark-baum_image

Mark Baum
Mark Baum Founder @ Eton Pharmaceuticals
Founder
2017-05-01

sean-brynjelsen_image

Sean Brynjelsen
Sean Brynjelsen Chief Executive Officer @ Eton Pharmaceuticals
Chief Executive Officer
2017-06-01

james-gruber_image

James Gruber
James Gruber CFO @ Eton Pharmaceuticals
CFO
2022-04-01

Founder


mark-baum_image

Mark Baum

Stock Details


Company's stock symbol is NASDAQ:ETON

Key Employee Changes

Date New article
2022-04-11 Eton Pharmaceuticals Names James Gruber Finance Chief

Official Site Inspections

http://www.etonpharma.com Semrush global rank: 1.42 M Semrush visits lastest month: 19.7 K

  • Host name: 149.199.83.34.bc.googleusercontent.com
  • IP address: 34.83.199.149
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Eton Pharmaceuticals"

Board of Directors | Eton Pharmaceuticals

Notable Experience and Activities. Healthcare leadership roles for over 30 years; Extensive experience leading, transforming, and driving growth in both Fortune 500 public and private equity-backed companies, as well as deep expertise โ€ฆSee details»

Company | Eton Pharmaceuticals

At Eton, we donโ€™t focus on a single therapeutic area or category. Instead, we provide hope by sourcing potential therapies worldwide.See details»

Corporate Profile - Eton Pharmaceuticals, Inc.

21925 W. Field Pkwy #235 Deer Park, IL 60010 (847) 787-7361See details»

Eton Pharmaceuticals Announces Appointment of Jenn Adams to โ€ฆ

DEER PARK, Ill., March 17, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing โ€ฆSee details»

Eton Pharmaceuticals, Inc. (ETON) - Yahoo Finance Canada

See the company profile for Eton Pharmaceuticals, Inc. (ETON) including business summary, industry/sector information, number of employees, business summary, corporate governance, โ€ฆSee details»

Eton Pharmaceuticals - Crunchbase Company Profile

Eton Pharmaceuticals reported its financial results for the fourth quarter and full year 2023, as well as the first quarter of 2024. The company announced the submission of a new drug application to the FDA for ET-400 (Hydrocortisone โ€ฆSee details»

Eton Pharmaceuticals, Inc. (ETON) Company Profile & Facts

See the company profile for Eton Pharmaceuticals, Inc. (ETON) including business summary, industry/sector information, number of employees, business summary, corporate governance, โ€ฆSee details»

Investor Relations | Eton Pharmaceuticals, Inc.

Oct 3, 2024 Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million , or $0.02 per diluted share Entered into an asset purchase agreement to acquire Increlex® โ€ฆSee details»

Leadership Team | Eton Pharmaceuticals

Notable Experience. Vice President, US Controller at Horizon Therapeutics, a branded pharmaceutical company where he was responsible for several areas of accounting, finance, and shared services, along with Sarbanes-Oxley โ€ฆSee details»

Bausch Health Acquires Eton Pharmaceuticals' EM-100 โ€ฆ

Feb 19, 2019 For more information, visit www.etonpharma.com. About Bausch + Lomb Bausch + Lomb, a Bausch Health Companies Inc. company, is a leading global eye health โ€ฆSee details»

Mission | Eton Pharmaceuticals

21925 W. Field Pkwy #235 Deer Park, IL 60010 (847) 787-7361See details»

Eton Pharmaceuticals Reports Record Revenue and Earnings

Mar 31, 2021 To access the conference call, please dial 1-866-795-8473 (domestic) or 1-470-495-9161 (international) and refer to conference ID 5847989. The webcast can be accessed โ€ฆSee details»

Eton Pharmaceuticals Announces Acquisition of Approved

DEER PARK, Ill., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing โ€ฆSee details»

Eton Pharmaceuticals Announces Acquisition of FDA-Approved

Sep 13, 2022 Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral SolutionSee details»

Eton Pharmaceuticals Announces Acquisition of FDA-Approved โ€ฆ

-- Expected to be accretive to 2023 earnings --DEER PARK, Ill., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals (โ€œEtonโ€ or โ€œthe Companyโ€) (Nasdaq: ETON), an โ€ฆSee details»

Business Model | Eton Pharmaceuticals

We strive to develop our therapies, file for FDA approval, and launch them with unprecedented speed. Below are a few examples of the types of value Eton tries to unlock:See details»

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to โ€ฆ

Nov 25, 2024 For more information, please visit our website at www.etonpharma.com. Forward-Looking Statements. Statements contained in this press release regarding matters that are not โ€ฆSee details»

Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2020 ...

DEER PARK, Ill., March 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing โ€ฆSee details»

Products | Eton Pharmaceuticals

21925 W. Field Pkwy #235 Deer Park, IL 60010 (847) 787-7361See details»

linkstock.net © 2022. All rights reserved